NatWest Group plc
- SEC CIK
- 0000844150
- Latest filing
- Aug 10, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by NatWest Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −6,691−100.0% | Sold out | Holders |
| Q1 2024 | 6,691 | $2.80M | 1.1% | −203−2.9% | Reduced | Holders |
| Q4 2023 | 6,894 | $2.81M | 1.2% | +1,068+18.3% | Added | Holders |
| Q3 2023 | 5,826 | $2.03M | 1.1% | +127+2.2% | Added | Holders |
| Q2 2023 | 5,699 | $2.01M | 1.0% | +14+0.2% | Added | Holders |
| Q1 2023 | 5,685 | $1.79M | 1.0% | −13,639−70.6% | Reduced | Holders |
| Q4 2022 | 19,324 | $5.58M | 3.2% | +406+2.1% | Added | Holders |
| Q3 2022 | 18,918 | $5.48M | 3.2% | +18,918 | New | Holders |